MENU
ADTX
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Aditxt (ADTX) Ownership - Who owns Aditxt?
Aditxt Inc is a life sciences company that develops, builds, and grows innovations with a focus on monitoring and modulating the immune system... Show more
Profile
Industry
N/A
Address
737 North Fifth Street
Phone
+1 650 870-1200
Employees
61
Web
https://www.aditxt.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
2.93M
P/E Ratio
N/A
Total Cash
476.42K
Projected Growth
N/A
Total Debt
4.07M
Revenue
55.32K
Risk (Beta)
1.64
Dividend Yield
N/A
Total Cash/Share
0.22
Total Debt/Equity
N/A
Revenue/Share
0.05 USD as % of share price
Fundamentals
ADTX
Capitalization
2.93M
P/E Ratio
N/A
Risk (Beta)
1.64
Dividend Yield
N/A
Total Cash
476K
Total Cash/Share
0.22
Total Debt
4.07M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.05%
Revenue
55.3K
ROE
N/A
Book Value
16.6M
P/B Ratio
0.18
Cash Flow
N/A
Earnings
-25.94
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
1.21K
Current Ratio
0.08
Current Revenue Per Employee
39.15
Dividends Per Share - Security
N/A
EBITDA
-20.96M
Float
N/A
Float - Current
N/A
Gross Income Margin
27.90
Revenue To Assets
-105.86
Shares Held By Institutions
94.1K
Shares Outstanding - Current
2.12M
Total Liabilities
15.5M
Total Volume MTD
N/A
Value
1
Gain YTD
-97.092
View a ticker or compare two or three
VS
VS
Show more...
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a life sciences company which engages in the development of nucleic acid (DNA)-based technologies to minimize rejection of transplanted organs by human recipients as well as address autoimmune diseases and allergies
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
737 North Fifth Street
Phone
+1 650 870-1200
Employees
61
Web
https://www.aditxt.com